The ongoing COVID-19 pandemic—and the worldwide reaction to it—has compelled companies to radically rethink their strategies and the way they operate. We salute the industry experts helping companies survive and sustain in this pandemic.

At MarketsandMarkets™, analysts are undertaking continuous efforts to provide analysis of the COVID-19 impact on the Allergy Diagnostics Market. We are working diligently to help companies take rapid decisions by studying:

· The impact of COVID-19 on the Allergy Diagnostics Market, including growth/decline in product type/use cases due to the cascaded impact of COVID-19 on the extended ecosystem of the market

· The rapid shifts in the strategies of the Top 50 companies in the Allergy Diagnostics Market

· The shifting short-term priorities of the top 50 companies’ clients and their client’s clients

You can request an in-depth analysis detailing the impact of COVID-19 on the Allergy Diagnostics Market: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=232871701

According to the recent report “Allergy Diagnostics Market by Products (Assay Kits, Immunoassay & Elisa Analyzers, Luminometers, Services), Allergens (Food, Inhaled, Drug), Tests (In Vivo, In Vitro), End Users (Hospital, Diagnostic Laboratory) – Global Forecast to 2022”,published by MarketsandMarkets™, is estimated to grow at a CAGR of 10.5% during the forecast period, to reach USD 5.7 billion.

Browse in-depth TOC on “Allergy Diagnostics Market”

105 – Tables

32 – Figures

149 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=232871701

Assay kits dominated the allergy diagnostics market in 2017

Based on product & service, the allergy diagnostics market is segmented into assay kits, instruments, and services. Assay kits form the largest and the fastest-growing segment in this market majorly due to the wide availability, large consumption, and the need for the repeat purchase of these kits in allergy testing. Although the cost of instruments is significantly higher than that of assay kits, they account for a lower share of the market owing to their long lifespan (the lifespan of a single instrument is 5 to 10 years) and the limited need for repeat installations. Also, there is a secondary market for used instruments, which are majorly procured by smaller healthcare organizations that cannot afford new instruments.

The inhaled allergens segment is expected to grow at the highest CAGR during the forecast period

Based on the allergen, the allergy diagnostics market is segmented into inhaled allergens, food allergens, drug allergens, and other allergens. The inhaled allergens segment is expected to witness the highest growth during the forecast period owing to the increasing environmental pollution levels across the globe.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=232871701

North America is the largest regional market for allergy diagnostics

The allergy diagnostics market is segmented into four major regions, namely, North America, Europe, Asia, and the Rest of the World. In 2017, North America accounted for the largest share of this market owing to the high healthcare expenditure and the strong presence of key market players in the region. These factors, coupled with the rising prevalence of different types of allergies, have resulted in the wide availability and adoption of various allergy diagnostic products and services in the US and Canada.

The key players operating in the allergy diagnostics market include Thermo Fisher Scientific Inc. (US), Siemens AG (Germany), Danaher Corporation (US), Omega Diagnostics Group PLC (UK), Hitachi Chemical Co., Ltd. (Japan), bioMérieux SA (France), Stallergenes Greer (UK), HOB Biotech Group Suzhou Co., Ltd. (China), HYCOR Biomedical (US), Lincoln Diagnostics, Inc. (US), EUROIMMUN AG (Germany), INDOOR Biotechnologies, Inc. (US), DR. FOOKE – Achterrath Laboratorien GmbH (Germany)